14-9099-37

Kennedy E, Coulter E, Halliwell E, Profitos-Peleja N, Walsby E, Clark B, Phillips EH, Burley TA, Mitchell S, Devereux S, Fegan CD, Jones CI, Johnston R, Chevassut T, Schulz R, Seiffert M, Agathanggelou A, Oldreive C, Davies N, Stankovic T, Liloglou T, Pepper C, Pepper AGS
Blood 2021 Jun 3;137(22):3064-3078

Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells.

Komlósi ZI, Kovács N, van de Veen W, Kirsch AI, Fahrner HB, Wawrzyniak M, Rebane A, Stanic B, Palomares O, Rückert B, Menz G, Akdis M, Losonczy G, Akdis CA
The Journal of allergy and clinical immunology 2018 Jul;142(1):178-194.e11

Altered Toll-like receptor expression and function in HPV-associated oropharyngeal carcinoma.

Tobouti PL, Bolt R, Radhakrishnan R, de Sousa SCOM, Hunter KD
Oncotarget 2018 Jan 2;9(1):236-248

ICOS(+) Foxp3(+) TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.

Nagase H, Takeoka T, Urakawa S, Morimoto-Okazawa A, Kawashima A, Iwahori K, Takiguchi S, Nishikawa H, Sato E, Sakaguchi S, Mori M, Doki Y, Wada H
International journal of cancer 2017 Feb 1;140(3):686-695

Toll-like receptor-9 in hypoxic nasopharyngeal carcinoma cells and its correlation with cell proliferation and apoptosis.

Zhang F, Wang D, Chen F
Oncology letters 2017 Dec;14(6):7829-7832

Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.

Zheng Y, Qin Z, Ye Q, Chen P, Wang Z, Yan Q, Luo Z, Liu X, Zhou Y, Xiong W, Ma J, Li G
Laboratory investigation; a journal of technical methods and pathology 2014 Nov;94(11):1188-99

A consensus surface activation marker signature is partially dependent on human immunodeficiency virus type 1 Nef expression within productively infected macrophages.

Babu R, Brown A
Retrovirology 2013 Dec 16;10:155

Cytoplasmic targeting motifs control localization of toll-like receptor 9.

Leifer CA, Brooks JC, Hoelzer K, Lopez J, Kennedy MN, Mazzoni A, Segal DM
The Journal of biological chemistry 2006 Nov 17;281(46):35585-92

Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils.

József L, Khreiss T, El Kebir D, Filep JG
Journal of immunology (Baltimore, Md. : 1950) 2006 Jan 15;176(2):1195-202

Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

Lee HK, Dunzendorfer S, Soldau K, Tobias PS
Immunity 2006 Feb;24(2):153-63

Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19.

Hoene V, Peiser M, Wanner R
Journal of leukocyte biology 2006 Dec;80(6):1328-36

Human lung cancer cells express functionally active Toll-like receptor 9.

Droemann D, Albrecht D, Gerdes J, Ulmer AJ, Branscheid D, Vollmer E, Dalhoff K, Zabel P, Goldmann T
Respiratory research 2005 Jan 4;6(1):1

TLR9 is localized in the endoplasmic reticulum prior to stimulation.

Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM
Journal of immunology (Baltimore, Md. : 1950) 2004 Jul 15;173(2):1179-83

No comments: Submit comment

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: HEK 293 parent cells (left panel) and 293/hTLR9 transfected cells (right panel) were fixed and permeabilized and subsequently stained with either Anti-Rat IgG FITC (Product # 11-4811-85) alone (thin line) or with 1 µg of Anti-Human CD289 (TLR9) Purified followed by Anti-Rat IgG FITC (thick line).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: NULL

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 2. Expression levels of Toll-like receptor-9 (TLR-9) protein in each group at different time-points detected by western blot analysis. # Expression level of TLR-9 proetin in hyperoxia group was significantly higher than that in control group at each time-point; ## expression of TLR-9 proten in hypoxia group was significantly higher than that in hyperoxia group at each time-point; *expression level of TLR-9 protein in hypoxia group reached the peak.